Synergy CHC CorpSNYR
Price$0.09

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $27.7M-20.5% YoYTTM through 31 Mar 2026
Net Income -$15.8M-842.9% YoYTTM through 31 Mar 2026
Free Cash Flow -$3.8MTTM through 31 Mar 2026

Margins

Current
Gross Margin72.3%
EBITDA Margin-39.1%
Operating Margin-10.4%
Net Margin-57.0%

Returns

62.1%ROE

Balance Sheet Health

Debt / Equity-1.09x
Current Ratio0.93x
Net Debt$27.5M
Cash & Equivalents$292.1K

Quality Metrics

Altman Z-Score-14.17
Piotroski F-Score2 / 9
FCF Margin-13.7%
Rule of 400.0
Earnings-Beat Rate0.0%

Multi-Year Trend

Revenue
'15'16'17'18'23'24'25
FY2025: $30.4M
Diluted EPS
'12'13'17'18'23'24'25
FY2025: $-1.27

Dividend

No dividend

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.